Incretins: The novel therapy of type 2 diabetes
Type 2 diabetes mellitus is a worldwide health problem. Adequate glycemic control can help to prevent many chronic diabetic complications. Despite the availability of several classes of oral hypoglycemic agents and insulin, many patients fail to achieve adequate glycemic control. Incretins are gut h...
Saved in:
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Review |
| Published: |
2018
|
| Subjects: | |
| Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/19641 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | Mahidol University |
| id |
th-mahidol.19641 |
|---|---|
| record_format |
dspace |
| spelling |
th-mahidol.196412018-07-12T09:42:06Z Incretins: The novel therapy of type 2 diabetes Nuntakon Thongtang Apiradee Sriwijitkamol Mahidol University Medicine Type 2 diabetes mellitus is a worldwide health problem. Adequate glycemic control can help to prevent many chronic diabetic complications. Despite the availability of several classes of oral hypoglycemic agents and insulin, many patients fail to achieve adequate glycemic control. Incretins are gut hormones produced in response to ingestion of nutrients. Glucagon-like peptide-1 (GLP-1), one of the incretin hormones, has pleiotropic actions on the control of blood glucose. Clinical trials with the incretin mimetic and Dipeptidyl peptidase-IV inhibitors demonstrate promising results in the improvement of glucose homeostasis. 2018-07-12T02:42:06Z 2018-07-12T02:42:06Z 2008-06-01 Review Journal of the Medical Association of Thailand. Vol.91, No.6 (2008), 943-954 01252208 01252208 2-s2.0-47149103357 https://repository.li.mahidol.ac.th/handle/123456789/19641 Mahidol University SCOPUS https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=47149103357&origin=inward |
| institution |
Mahidol University |
| building |
Mahidol University Library |
| continent |
Asia |
| country |
Thailand Thailand |
| content_provider |
Mahidol University Library |
| collection |
Mahidol University Institutional Repository |
| topic |
Medicine |
| spellingShingle |
Medicine Nuntakon Thongtang Apiradee Sriwijitkamol Incretins: The novel therapy of type 2 diabetes |
| description |
Type 2 diabetes mellitus is a worldwide health problem. Adequate glycemic control can help to prevent many chronic diabetic complications. Despite the availability of several classes of oral hypoglycemic agents and insulin, many patients fail to achieve adequate glycemic control. Incretins are gut hormones produced in response to ingestion of nutrients. Glucagon-like peptide-1 (GLP-1), one of the incretin hormones, has pleiotropic actions on the control of blood glucose. Clinical trials with the incretin mimetic and Dipeptidyl peptidase-IV inhibitors demonstrate promising results in the improvement of glucose homeostasis. |
| author2 |
Mahidol University |
| author_facet |
Mahidol University Nuntakon Thongtang Apiradee Sriwijitkamol |
| format |
Review |
| author |
Nuntakon Thongtang Apiradee Sriwijitkamol |
| author_sort |
Nuntakon Thongtang |
| title |
Incretins: The novel therapy of type 2 diabetes |
| title_short |
Incretins: The novel therapy of type 2 diabetes |
| title_full |
Incretins: The novel therapy of type 2 diabetes |
| title_fullStr |
Incretins: The novel therapy of type 2 diabetes |
| title_full_unstemmed |
Incretins: The novel therapy of type 2 diabetes |
| title_sort |
incretins: the novel therapy of type 2 diabetes |
| publishDate |
2018 |
| url |
https://repository.li.mahidol.ac.th/handle/123456789/19641 |
| _version_ |
1763493886816157696 |